U.S. markets close in 4 hours 39 minutes

Tibet Pharmaceuticals, Inc. (TBET)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.01100.0000 (0.00%)
As of 9:52AM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 6/23/2021
Current
Market Cap (intraday) 5
N/A
Enterprise Value 3
N/A
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 7
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 6.50
52-Week Change 312,900.00%
S&P500 52-Week Change 339.21%
52 Week High 30.1000
52 Week Low 30.0001
50-Day Moving Average 30.0189
200-Day Moving Average 30.0076

Share Statistics

Avg Vol (3 month) 344.84k
Avg Vol (10 day) 385.01k
Shares Outstanding 514.85M
Implied Shares Outstanding 6N/A
Float N/A
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2010
Most Recent Quarter (mrq)Sep 29, 2011

Profitability

Profit Margin 31.79%
Operating Margin (ttm)31.70%

Management Effectiveness

Return on Assets (ttm)17.44%
Return on Equity (ttm)32.15%

Income Statement

Revenue (ttm)34.05M
Revenue Per Share (ttm)2.45
Quarterly Revenue Growth (yoy)-4.90%
Gross Profit (ttm)16.18M
EBITDA 11.53M
Net Income Avi to Common (ttm)10.82M
Diluted EPS (ttm)0.7790
Quarterly Earnings Growth (yoy)-57.10%

Balance Sheet

Total Cash (mrq)25.96M
Total Cash Per Share (mrq)1.75
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)14.48
Book Value Per Share (mrq)3.18

Cash Flow Statement

Operating Cash Flow (ttm)6.03M
Levered Free Cash Flow (ttm)1.07M